Published in Clin Liver Dis on November 01, 1997
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25
The natural history of hepatitis C virus (HCV) infection. Int J Med Sci (2006) 3.13
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology (2010) 2.64
Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev (2000) 2.45
Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C. J Gastroenterol (2007) 1.85
Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication. Virol J (2005) 1.46
Self-assembling peptide nanotubes with antiviral activity against hepatitis C virus. Chem Biol (2011) 1.41
Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health (2012) 1.35
KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol (2016) 1.15
Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection. Proc Natl Acad Sci U S A (2009) 1.11
Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada. J Urban Health (2004) 1.10
KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol (2014) 0.99
Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect Dis (2002) 0.97
Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5' noncoding and nonstructural 5b genomic regions. J Clin Microbiol (2007) 0.96
Clinical characteristics, spontaneous clearance and treatment outcome of acute hepatitis C: a single tertiary center experience. Saudi J Gastroenterol (2013) 0.84
Hepatitis C virus screening and management of seroconversions in hemodialysis facilities. Semin Dial (2013) 0.84
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol (2016) 0.83
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance. BMC Infect Dis (2001) 0.82
Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication. Antimicrob Agents Chemother (2008) 0.80
Enhanced anti-HCV activity of interferon alpha 17 subtype. Virol J (2009) 0.78
The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil. BMC Infect Dis (2012) 0.76
Evaluation of Dual Therapy in Real Life Setting in Treatment-Naïve Turkish Patients with HCV Infection: A Multicenter, Retrospective Study. Balkan Med J (2016) 0.75
Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection. AIDS (2016) 0.75
Demographics of Hepatitis C in Southwest Ohio (2010 to 2015). Hepat Mon (2016) 0.75
Nurses' Knowledge toward Hepatitis B and Hepatitis C in Guilan, Iran. Open Nurs J (2017) 0.75